ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents targeting interleukins, immunoglobulins and complement factors).
Winthrop K.L., Mariette X., Silva J.T., Benamu E., Calabrese L.H., Dumusc A., Smolen J.S., Aguado J.M., Fernández-Ruiz M., 2018/06. Clinical microbiology and infection, 24 Suppl 2 pp. S21-S40. Peer-reviewed.
ici le détail